Melody Harris

Former Chief Operations Officer and Former President, Oncology Data SolutionsatNeogenomics· In proxies 2021–2025

Pay in FY2025+28% from the year before · Neogenomics stock -28.6% the same year

Melody Harris was paid $3.7M in FY2025 (Dec), up 28%. Neogenomics stock fell 28.6% that year.

Pay$100 in the stock at the end of FY20 → $22

Pay is from the Summary Compensation Table of each Neogenomics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

NeogenomicsPublic company · 5 yr
- Former Chief Operations Officer and Former President, Oncology Data Solutions2021 – Present · 5 yrStock in role -68%

Roles come from the proxy statements of each company.

Activity

Pay
Neogenomics Former Chief Operations Officer and Former President, Oncology Data Solutions pay rose 28% to $3.7M. The stock fell 29% in FY2025 (Dec).
DEF 14AApr 6, 2026
Pay
Neogenomics Former Chief Operations Officer and Former President, Oncology Data Solutions pay fell 39% to $2.9M. The stock rose 2% in FY2024 (Dec).
DEF 14AApr 8, 2025

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?